1. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
   Mireille M. Hermans et al, 2022, Acta Dermato-Venereologica CrossRef
2. Vascular Birthmarks: Vascular Malformations and Haemangiomas
   Fabio Arcangeli et al, 2023, European Handbook of Dermatological Treatments CrossRef
3. Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study
   Sasha Wilson et al, 2022, JPRAS Open CrossRef
4. Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents
   Mireille M. Hermans et al, 2024, Dermatology CrossRef
5. Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol
   Tiffany Chen et al, 2023, Annals of Otology, Rhinology & Laryngology CrossRef
6. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
   Mireille M. Hermans et al, 2022, European Journal of Pediatrics CrossRef
7. Case Report and Literature Review: Bisphosphonate, Sirolimus, and Atenolol Treatment in a 4-Year-Old Child Diagnosed with Gorham–Stout Disease
   Su Jin Park et al, 2023, Pharmaceuticals CrossRef
8. Update on infantile hemangioma
   Hye Lim Jung, 2021, Clinical and Experimental Pediatrics CrossRef
9. Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers
   Mireille M. Hermans et al, 2023, Acta Dermato-Venereologica CrossRef